1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.
123.56 -0.65 (-0.52%)
851.5K
XNAS Volume

XNAS 27 Jun, 2025 5:30 PM (EDT)

Repligen Corp. - RGEN - stock price prediction, stock price target, analyst ratings from 20 analysts

Repligen Corp. has a share price target of US$ 181, revenue growth forecast of 11.8%, and profit growth estimate of 280.9% for FY25, based on top 20 analyst calls.